Dacarbazine Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9245

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dacarbazine (NDC 0143-9245). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Dacarbazine For Injection Usp 1)

FDA Label Image

Vial (Dacarbazine For Injection Usp 2)

Vial (Dacarbazine For Injection Usp 2)
NDC 0143-9245-01 is Dacarbazine for Injection, USP with a dosage of 200 mg per citrate salt for intravenous use and is a cytotoi. The dosage recommendation is not available as the text is corrupted by and has missing information. The drug needs to be stored in a refrigerator at 2-8 degrees Celsius.*
FDA Label Image

Carton (Dacarbazine For Injection Usp 3)

Carton (Dacarbazine For Injection Usp 3)
Dacarbazine for Injection, USP is a medication used for cancer treatment. It is not possible to determine more details from the scanned text.*
FDA Label Image

Serialization (Dacarbazine For Injection Usp 4)

Serialization (Dacarbazine For Injection Usp 4)
This is a product identification code consisting of a Global Trade Item Number (GTIN), serial number (SN), expiration date (EXP), and lot number (LOT). Not available for further information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.